Complement has long been associated with AD; many studies have shown complement proteins, including C1q, clusterin, and FH, co-localising with Aβ plaques, and significant alterations in complement mRNA and protein levels in brain, plasma, and CSF in AD [12, 40]. The gene discussed is CLU; the disease is Alzheimer disease.